v3.25.1
Condensed Consolidated Statements Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Restricted Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Common stock, outstanding balance as of beginning of the period (in shares) at Dec. 31, 2023 [1]   69,242,940        
Equity, balance as of beginning of the period at Dec. 31, 2023 $ (34,361) $ 7   $ 27,125 $ (61,493) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) [1]   1,345,625        
Exercise of stock options 440     440    
Stock-based compensation 667     667    
Change in unrealized loss on marketable debt securities 0          
Net loss (24,022)       (24,022)  
Common stock, outstanding balance as of end of the period (in shares) at Mar. 31, 2024 [1]   70,588,565        
Equity, balance as of end of the period at Mar. 31, 2024 $ (57,276) $ 7   28,232 (85,515) 0
Common stock, outstanding balance as of beginning of the period (in shares) at Dec. 31, 2024 137,706,596 137,706,596        
Equity, balance as of beginning of the period at Dec. 31, 2024 $ 250,857 $ 14   383,739 (135,109) 2,213
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   318,921        
Exercise of stock options 720     720    
Issuance of stock in connection with acquisition of business (in shares)   820,840 274,339      
Issuance of stock in connection with acquisition of business 27,408     27,408    
Issuance of common stock for restricted stock units (in shares)   134,832        
Common stock withheld for taxes (in shares)   (66,724)        
Common stock withheld for taxes (1,595)     (1,595)    
Stock-based compensation 2,311     2,311    
Change in unrealized loss on marketable debt securities (561)         (561)
Net loss $ (9,810)       (9,810)  
Common stock, outstanding balance as of end of the period (in shares) at Mar. 31, 2025 139,188,804 139,188,804        
Equity, balance as of end of the period at Mar. 31, 2025 $ 269,330 $ 14   $ 412,583 $ (144,919) $ 1,652
[1] The shares of the Company’s common stock prior to the Recapitalization have been retrospectively recast to reflect the change in the capital structure as a result of the Recapitalization as described in Note 1.